Clinical Study
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation
Table 1
Clinical effects after one month of Sativex medication. Data are reported as mean ± sd. The asterisk refers to the significant modification at , in comparison to ( < 0.05, < 0.01).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
EDDS: Expanded Disability Scale; MAS: Modified Ashworth Scale; NRS: numerical rating scale; 10 WT: ten-meter walking test in seconds of walk-through (s) and percent of patients able to perform the test (%); AI: Ambulation Index; pVAS: visual analogic scale for chronic pain rating; PSFS: Penn spasm frequency scale; BLCS: bladder control scale; MSQoL: Multiple Sclerosis Quality of Life scale. |